Evidence map›Paper›PMID 34049975›Full record

ArticleCancer research2021

Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1.

Samantha B Kemp, Eileen S Carpenter, Nina G Steele, Katelyn L Donahue, Zeribe C Nwosu, Amanda Pacheco, Ashley Velez-Delgado, Rosa E Menjivar, Fatima Lima, Stephanie The and 8 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 2 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 2 syntheses or guidelines pooled it, 192 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Translational cancer research · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hypoxia Impairs CD8Cancers · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Samantha B KempProgram in Molecular and Cellular Pathology, University of Michigan, Ann Arbor, Michigan.
Eileen S CarpenterDepartment of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.
Nina G SteeleDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan.
Katelyn L DonahueProgram in Cancer Biology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9535-9275
Zeribe C NwosuDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-1641-2045
Amanda PachecoProgram in Cancer Biology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-7108-2128
Ashley Velez-DelgadoDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan.
Rosa E MenjivarProgram in Cellular and Molecular Biology, University of Michigan, Ann Arbor, Michigan.
Fatima LimaDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.
Stephanie TheDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.
Carlos E EspinozaDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.
Kristee BrownDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.
Daniel LongDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.
Costas A LyssiotisDepartment of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9309-6141
Arvind RaoDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9613-426X
Yaqing ZhangDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.
Marina Pasca di MaglianoDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan. hcrawfo1@hfhs.org marinapa@umich.edu.ORCID 0000-0001-9632-9035
Howard C CrawfordDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan. hcrawfo1@hfhs.org marinapa@umich.edu.ORCID 0000-0001-9360-3019
University of Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
University of Michigan Postbaccalaureate Research Education Program (UM PREP)R25GM086262 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALLEN, BENJAMIN · 2009 to 2024
$6.1M
Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade GliomasR37CA214955 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KURTEK, SEBASTIAN, RAO, ARVIND · 2018 to 2024
$3.9M
Training in Basic and Translational Digestive SciencesT32DK094775 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHN Y KAO, LINDA C. SAMUELSON · 2012 to 2026
$3.6M
Mechanisms of Pancreatic Inflammation, Tissue Repair and CarcinogenesisR01CA151588 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PASCA DI MAGLIANO, MARINA · 2010 to 2020
$3.3M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas CancerU01CA224145 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRAWFORD, HOWARD C., PASCA DI MAGLIANO, MARINA · 2017 to 2021
$2.6M
Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic CancerR37CA237421 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Costas Andreas Lyssiotis · 2020 to 2026
$2.6M
Stromal metabolism promotes therapeutic resistance in pancreatic cancerR01CA248160 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$2.0M
NCI NIH HHS F31 CA247076NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA151588NCI NIH HHS R01 CA198074NCI NIH HHS R01 CA248160NCI NIH HHS R37 CA214955NCI NIH HHS R37 CA237421NCI NIH HHS R50 CA232985NCI NIH HHS T32 CA009676NCI NIH HHS U01 CA224145NIDDK NIH HHS P30 DK034933NIDDK NIH HHS T32 DK094775NIGMS NIH HHS R25 GM086262NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32 GM113900NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with few effective therapeutic options. PDAC is characterized by an extensive fibroinflammatory stroma that includes abundant infiltrating immune cells. Tumor-associated macrophages (TAM) are prevalent within the stroma and are key drivers of immunosuppression. TAMs in human and murine PDAC are characterized by elevated expression of apolipoprotein E (ApoE), an apolipoprotein that mediates cholesterol metabolism and has known roles in cardiovascular and Alzheimer's disease but no known role in PDAC. We report here that ApoE is also elevated in peripheral blood monocytes in PDAC patients, and plasma ApoE protein levels stratify patient survival. Orthotopic implantation of mouse PDAC cells into syngeneic wild-type or in

Indexed as

AnimalsApolipoproteins ECell Line, TumorChemokine CXCL1FibroblastsHumansImmune SystemImmunosuppression TherapyInflammationMacrophagesMass SpectrometryMiceMice, Inbred C57BLMice, Knockout, ApoENF-kappa BPancreatic NeoplasmsApoE protein, humanApoe protein, mouseApolipoproteins EChemokine CXCL1CXCL1 protein, humanCxcl1 protein, mouseNF-kappa BReceptors, LDL

Identifiers

PMID34049975
PMCPMC8445065
OpenAlexW3164787484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.